AvaALL: Bevacizumab Beyond Progression in Patients with Metastatic Non-Squamous NSCLC - 100459

Spotlight
Video

AvaALL: Bevacizumab Beyond Progression in Patients with Metastatic Non-Squamous NSCLC

moasc has 332 videos Subscribe Here

Loading........
Description: Viola Zhu, MD, PhD of UC Irvine Health discusses the AvaALL trial and the use of bevacizumab beyond progression in patients with non-small cell lung cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.

Abstract 90040: AvaALL: Use of Bevacizumab Beyond Progression
Shared By : moasc
Posted on : 08/02/17
Added : 1 year ago